Trial Profile
Effects of Exenatide on excess daytime sleepiness (EDS), wakefulness and driving performance in obese type-2 diabetes patients without sleep apnea – proof of concept study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Apr 2012
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 22 Nov 2011 New trial record